首页 > 最新文献

Acta Endocrinologica-Bucharest最新文献

英文 中文
ANALYSIS OF PUBLIC INTEREST ABOUT OSTEOPOROSIS USING GOOGLE TRENDS: ARE SEASON AND ECONOMY EFFECTIVE? 利用谷歌趋势分析公众对骨质疏松症的兴趣:季节性和经济性是否有效?
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-01 Epub Date: 2025-01-18 DOI: 10.4183/aeb.2024.121
B T Dede, M Oğuz, B Alyanak, F Bağcıer

Background: The aim of this study was to assess the awareness of the USA and world population about osteoporosis, taking into account seasonal variations and economic conditions.

Methods: The term "osteoporosis" was searched using Google Trends between January 1, 2004 and September 12, 2024. Cosinor analysis was used to test the effect of seasonality on relative search volumes (RSV) for osteoporosis searches in the USA and worldwide. LOESS (Locally Estimated Scatterplot Smoothing) was used to decompose a time series into its seasonal component, trend component, and residual component. We also analysed RSV values in US states according to income levels.

Results: It is seen that RSV values in the USA and the world have been in a decreasing trend from 2004 to 2014, but after 2015, they have been in an increasing trend. According to the results of the cosinor analysis, RSV values in the US and worldwide are highest in the fall months and lowest in the summer months. Significant differences were found in search trends between seasons in both the US and the world (p<0.05). There is no statistically significant difference in RSV values by income level worldwide and in the USA (p>0.05).

Conclusion: Osteoporosis appears to be a global health problem and a major focus of attention, both in the US and around the world. Health strategies to increase osteoporosis awareness can be planned to address different income groups, taking into account regional and seasonal effects.

背景:本研究的目的是评估美国和世界人口对骨质疏松症的认识,考虑到季节变化和经济条件。方法:在2004年1月1日至2024年9月12日期间,使用谷歌Trends检索“骨质疏松症”一词。余弦分析用于检验季节性对美国和全球骨质疏松症搜索相对搜索量(RSV)的影响。采用局部估计散点图平滑法将时间序列分解为季节分量、趋势分量和残差分量。我们还根据收入水平分析了美国各州的RSV值。结果:2004 - 2014年美国及全球RSV值呈下降趋势,2015年以后呈上升趋势。根据余弦分析的结果,美国和世界各地的RSV值在秋季最高,在夏季最低。美国和世界不同季节的搜索趋势有显著差异(p0.05)。结论:骨质疏松症似乎是一个全球性的健康问题和关注的主要焦点,无论是在美国和世界各地。可针对不同的收入群体制定保健战略,提高对骨质疏松症的认识,同时考虑到区域和季节性影响。
{"title":"ANALYSIS OF PUBLIC INTEREST ABOUT OSTEOPOROSIS USING GOOGLE TRENDS: ARE SEASON AND ECONOMY EFFECTIVE?","authors":"B T Dede, M Oğuz, B Alyanak, F Bağcıer","doi":"10.4183/aeb.2024.121","DOIUrl":"10.4183/aeb.2024.121","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to assess the awareness of the USA and world population about osteoporosis, taking into account seasonal variations and economic conditions.</p><p><strong>Methods: </strong>The term \"osteoporosis\" was searched using Google Trends between January 1, 2004 and September 12, 2024. Cosinor analysis was used to test the effect of seasonality on relative search volumes (RSV) for osteoporosis searches in the USA and worldwide. LOESS (Locally Estimated Scatterplot Smoothing) was used to decompose a time series into its seasonal component, trend component, and residual component. We also analysed RSV values in US states according to income levels.</p><p><strong>Results: </strong>It is seen that RSV values in the USA and the world have been in a decreasing trend from 2004 to 2014, but after 2015, they have been in an increasing trend. According to the results of the cosinor analysis, RSV values in the US and worldwide are highest in the fall months and lowest in the summer months. Significant differences were found in search trends between seasons in both the US and the world (p<0.05). There is no statistically significant difference in RSV values by income level worldwide and in the USA (p>0.05).</p><p><strong>Conclusion: </strong>Osteoporosis appears to be a global health problem and a major focus of attention, both in the US and around the world. Health strategies to increase osteoporosis awareness can be planned to address different income groups, taking into account regional and seasonal effects.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 2","pages":"121-126"},"PeriodicalIF":0.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SHORT HISTORY OF OBESITY. 肥胖史短。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-01 Epub Date: 2025-01-18 DOI: 10.4183/aeb.2024.207
D Micic, S Polovina, D Micic, V D Yumuk

Obesity epidemic, developed in recent decades with global dissemination, brings scientific interest in causes and consequences for mankind. It is of interest whether obesity existed under different, non-obesogenic environments in ancient time. There is evidence for particular obesity existence in artefacts and pictures from caves, originated in ancient times. Human female figurines from Stone Age that represent obesity were discovered in different countries indicating that some form of obesity existed 30.000 years ago. It is supposed that most of these figures represent in some way "Mother of Goddess " connected with fertility. Records from Ancient Egyptian and Biblical eras through Greco-Roman to Medieval times indicate that obesity was present throughout peoples of previous centuries in history, although peoples of previous centuries would probably have experienced overweight and obesity as exceptional rather than normal.

肥胖症的流行是近几十年来随着全球的传播而发展起来的,它给人类带来了对病因和后果的科学兴趣。在古代,肥胖是否存在于不同的非致肥环境中是一个有趣的问题。有证据表明,远古时代的人工制品和洞穴里的图画中存在着特别的肥胖。在不同的国家发现了代表肥胖的石器时代的人类女性雕像,这表明3万年前就存在某种形式的肥胖。据推测,这些人物中的大多数在某种程度上代表了与生育有关的“女神之母”。从古埃及和圣经时代到希腊罗马到中世纪的记录表明,肥胖在历史上的前几个世纪的人们中都存在,尽管前几个世纪的人们可能会经历超重和肥胖,而不是正常的。
{"title":"SHORT HISTORY OF OBESITY.","authors":"D Micic, S Polovina, D Micic, V D Yumuk","doi":"10.4183/aeb.2024.207","DOIUrl":"10.4183/aeb.2024.207","url":null,"abstract":"<p><p>Obesity epidemic, developed in recent decades with global dissemination, brings scientific interest in causes and consequences for mankind. It is of interest whether obesity existed under different, non-obesogenic environments in ancient time. There is evidence for particular obesity existence in artefacts and pictures from caves, originated in ancient times. Human female figurines from Stone Age that represent obesity were discovered in different countries indicating that some form of obesity existed 30.000 years ago. It is supposed that most of these figures represent in some way \"Mother of Goddess \" connected with fertility. Records from Ancient Egyptian and Biblical eras through Greco-Roman to Medieval times indicate that obesity was present throughout peoples of previous centuries in history, although peoples of previous centuries would probably have experienced overweight and obesity as exceptional rather than normal.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 2","pages":"207-211"},"PeriodicalIF":0.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE SERUM CREATININE TO CYSTATIN RATIO IN THYROTOXICOSIS PATIENTS: A CASE-CONTROL STUDY. 甲状腺毒症患者血清肌酐与胱抑素比值:一项病例对照研究。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-01 Epub Date: 2025-01-18 DOI: 10.4183/aeb.2024.143
Y Hu, H Peng, L Tong

Context: Previous studies have demonstrated a correlation between creatinine and cystatin levels and thyroid disorders.

Objective: To further investigate the diagnostic value of serum creatinine to cystatin C ratio in the diagnosis of thyrotoxicosis.

Design: One hundred eighty four thyrotoxicosis patients and 406 healthy controls were enrolled.

Subjects and methods: We assessed at baseline characteristics, serum Cr:Cyc in thyrotoxicosis group, control group and subgroups and analyzed the relationship between the indicator and the etiology of thyroid gland toxicity.

Results: Subgroup analysis indicated that the Cr:Cyc ratio in the Graves' disease (GD) group was lower than those in the Hashimoto's thyroiditis (HT) and subacute thyroiditis (SAT) groups (P<0.001). Correlation analysis demonstrated that the Cr:Cyc ratio was positively correlated with thyroid stimulating hormone (TSH) and thyrotropin receptor antibody (TRAb) but negatively correlated with free triiodothyronine (FT3) and free thyroxine (FT4) in the GD group. Receiver operating characteristic (ROC) curve analysis indicated that the area under the curve (AUC) value of the Cr:Cyc ratio for the diagnosis of thyrotoxicosis was 0.933 (P<0.001), and the AUC value for the diagnosis of GD was 0.778 (P<0.001).

Conclusion: The Cr:Cyc ratio has clinical significance in the diagnosis of thyrotoxicosis and the identification of thyrotoxicosis etiology.

背景:先前的研究已经证明肌酐和胱抑素水平与甲状腺疾病之间存在相关性。目的:进一步探讨血清肌酐与胱抑素C比值对甲状腺毒症的诊断价值。设计:纳入184名甲状腺毒症患者和406名健康对照者。研究对象和方法:评估甲状腺毒症组、对照组和亚组患者的基线特征、血清Cr:Cyc,并分析该指标与甲状腺毒性病因的关系。结果:亚组分析显示Graves病(GD)组Cr:Cyc比值低于桥本甲状腺炎(HT)和亚急性甲状腺炎(SAT)组(p)。结论:Cr:Cyc比值对甲状腺毒症的诊断和甲状腺毒症病因的鉴别有临床意义。
{"title":"THE SERUM CREATININE TO CYSTATIN RATIO IN THYROTOXICOSIS PATIENTS: A CASE-CONTROL STUDY.","authors":"Y Hu, H Peng, L Tong","doi":"10.4183/aeb.2024.143","DOIUrl":"10.4183/aeb.2024.143","url":null,"abstract":"<p><strong>Context: </strong>Previous studies have demonstrated a correlation between creatinine and cystatin levels and thyroid disorders.</p><p><strong>Objective: </strong>To further investigate the diagnostic value of serum creatinine to cystatin C ratio in the diagnosis of thyrotoxicosis.</p><p><strong>Design: </strong>One hundred eighty four thyrotoxicosis patients and 406 healthy controls were enrolled.</p><p><strong>Subjects and methods: </strong>We assessed at baseline characteristics, serum Cr:Cyc in thyrotoxicosis group, control group and subgroups and analyzed the relationship between the indicator and the etiology of thyroid gland toxicity.</p><p><strong>Results: </strong>Subgroup analysis indicated that the Cr:Cyc ratio in the Graves' disease (GD) group was lower than those in the Hashimoto's thyroiditis (HT) and subacute thyroiditis (SAT) groups (P<0.001). Correlation analysis demonstrated that the Cr:Cyc ratio was positively correlated with thyroid stimulating hormone (TSH) and thyrotropin receptor antibody (TRAb) but negatively correlated with free triiodothyronine (FT3) and free thyroxine (FT4) in the GD group. Receiver operating characteristic (ROC) curve analysis indicated that the area under the curve (AUC) value of the Cr:Cyc ratio for the diagnosis of thyrotoxicosis was 0.933 (P<0.001), and the AUC value for the diagnosis of GD was 0.778 (P<0.001).</p><p><strong>Conclusion: </strong>The Cr:Cyc ratio has clinical significance in the diagnosis of thyrotoxicosis and the identification of thyrotoxicosis etiology.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 2","pages":"143-152"},"PeriodicalIF":0.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PREDICTORS OF TSH NORMALIZATION IN THYROTOXICOSIS PATIENTS AFTER TREATMENT. 治疗后甲状腺毒症患者TSH正常化的预测因素。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-04-01 Epub Date: 2025-01-18 DOI: 10.4183/aeb.2024.193
C H Han, C H Yin, J S Chen, Y S Chen, C H Chu, W C Chuang, H C Hung

Context: Understanding factors delaying recovery in thyrotoxicosis patients is crucial for optimizing treatment plan.

Objective: This study aimed to identify predictive factors for the delayed thyroid function recovery in thyrotoxicosis patients.

Design: The study is a retrospective review of medical records of adult thyrotoxicosis patients diagnosed at Kaohsiung Veterans General Hospital, Taiwan, from January 2014 to December 2021. The duration of follow-up for the main outcome was at least 18 months.

Subjects and methods: Patients newly diagnosed with thyrotoxicosis who were age > 18 years old, had a TSH level <0.1 μIU/mL, received CBZ or PTU treatment, and demonstrated a subsequent TSH increase to above 0.4 μIU/mL, were included.

Results: The study included 443 patients. The average time to achieve normalized TSH levels was 6.9 months. Key factors associated with delayed TSH normalization included higher body mass index (BMI) [odds ratio (OR) = 1.06, confidence interval (CI): 1.01-1.12], elevated serum free T4 levels (OR = 1.97; CI, 1.44-2.69), and treatment with propylthiouracil (OR = 2.66; CI, 1.33-5.32). In contrast, factors such as sex, age, season of diagnosis, and comorbidities did not significantly impact the rate of TSH normalization.

Conclusion: The study highlights the importance of considering individual patient characteristics, such as BMI and initial free T4 levels, in thyrotoxicosis management. The findings suggest a potential preference for carbimazole over PTU in achieving faster TSH normalization. This research contributes to the understanding of thyrotoxicosis recovery and supports the need for personalized treatment approaches in clinical practice.

背景:了解甲状腺毒症患者延迟康复的因素对优化治疗方案至关重要。目的:探讨甲状腺毒症患者甲状腺功能恢复迟缓的预测因素。设计:本研究回顾性分析2014年1月至2021年12月在台湾高雄退伍军人总医院诊断的成人甲状腺毒症患者的医疗记录。主要结果的随访时间至少为18个月。研究对象和方法:新诊断为甲状腺功能亢进症的患者,年龄在bb0 ~ 18岁,TSH水平。达到正常TSH水平的平均时间为6.9个月。与TSH正常化延迟相关的关键因素包括较高的身体质量指数(BMI)[优势比(OR) = 1.06,可信区间(CI): 1.01-1.12]、血清游离T4水平升高(OR = 1.97;CI, 1.44-2.69),丙基硫脲嘧啶治疗组(OR = 2.66;CI, 1.33 - -5.32)。相比之下,性别、年龄、诊断季节和合并症等因素对TSH正常化率没有显著影响。结论:该研究强调了在甲状腺毒症管理中考虑个体患者特征(如BMI和初始游离T4水平)的重要性。研究结果表明,在实现更快的TSH正常化方面,卡咪唑可能比PTU更有优势。这项研究有助于了解甲状腺毒症的恢复,并支持在临床实践中需要个性化的治疗方法。
{"title":"PREDICTORS OF TSH NORMALIZATION IN THYROTOXICOSIS PATIENTS AFTER TREATMENT.","authors":"C H Han, C H Yin, J S Chen, Y S Chen, C H Chu, W C Chuang, H C Hung","doi":"10.4183/aeb.2024.193","DOIUrl":"10.4183/aeb.2024.193","url":null,"abstract":"<p><strong>Context: </strong>Understanding factors delaying recovery in thyrotoxicosis patients is crucial for optimizing treatment plan.</p><p><strong>Objective: </strong>This study aimed to identify predictive factors for the delayed thyroid function recovery in thyrotoxicosis patients.</p><p><strong>Design: </strong>The study is a retrospective review of medical records of adult thyrotoxicosis patients diagnosed at Kaohsiung Veterans General Hospital, Taiwan, from January 2014 to December 2021. The duration of follow-up for the main outcome was at least 18 months.</p><p><strong>Subjects and methods: </strong>Patients newly diagnosed with thyrotoxicosis who were age > 18 years old, had a TSH level <0.1 μIU/mL, received CBZ or PTU treatment, and demonstrated a subsequent TSH increase to above 0.4 μIU/mL, were included.</p><p><strong>Results: </strong>The study included 443 patients. The average time to achieve normalized TSH levels was 6.9 months. Key factors associated with delayed TSH normalization included higher body mass index (BMI) [odds ratio (OR) = 1.06, confidence interval (CI): 1.01-1.12], elevated serum free T4 levels (OR = 1.97; CI, 1.44-2.69), and treatment with propylthiouracil (OR = 2.66; CI, 1.33-5.32). In contrast, factors such as sex, age, season of diagnosis, and comorbidities did not significantly impact the rate of TSH normalization.</p><p><strong>Conclusion: </strong>The study highlights the importance of considering individual patient characteristics, such as BMI and initial free T4 levels, in thyrotoxicosis management. The findings suggest a potential preference for carbimazole over PTU in achieving faster TSH normalization. This research contributes to the understanding of thyrotoxicosis recovery and supports the need for personalized treatment approaches in clinical practice.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 2","pages":"193-200"},"PeriodicalIF":0.7,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OBSESSIVE COMPULSIVE DISORDER AND CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY IN WOLFRAM SYNDROME: NEW ASPECTS AND A NOVEL WFS1 MUTATION. 强迫症与沃尔夫拉姆综合征的生长和青春期发育迟缓:新的方面和一种新的 WFS1 基因突变。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.107
H Manyas, B Eroğlu Filibeli, I Ayrancı, Ö Kırbıyık, G Catli, B N Dundar

Introduction: Wolfram Syndrome (WS) is a rare autosomal recessively inherited disorder characterized by juvenile-onset diabetes mellitus (DM), diabetes insipidus, optic atrophy (OA), hearing loss and neurodegeneration. This report describes three cases with WS.

Case report: The first case was diagnosed with DM and OA at the age of 6 and 11 years, respectively. Second patient was the sibling of the first patient, also had DM and was investigated for WS after his brothers' diagnosis. The third patient was diagnosed with DM at the age of 5 years and developed bilateral sensorineural hearing loss and OA at the ages of 7 and 12 years, respectively. Preliminary diagnoses of all patients were confirmed by Sanger sequencing of the WFS1 gene. Two previously reported and a novel mutation were detected. While our first patient was diagnosed with attention deficit hyperactivity disorder previously described in WS patients, obsessive compulsive disorder observed in case 2, was not previously reported in WS to the best of our knowledge. Puberty delay was detected in our first patient and was diagnosed as constitutional delay of puberty and growth.

Conclusion: Early diagnosis of WS can lead to early detection of associated pathologies and to decrease complications, morbidity and mortality.

简介:沃尔夫拉姆综合征(WS)是一种罕见的常染色体隐性遗传疾病:沃尔夫拉姆综合征(WS)是一种罕见的常染色体隐性遗传疾病,其特征是青少年期发病的糖尿病(DM)、尿崩症、视神经萎缩(OA)、听力损失和神经变性。本报告描述了三个患有 WS 的病例:第一个病例分别在 6 岁和 11 岁时被诊断出患有 DM 和 OA。第二例患者是第一例患者的兄弟姐妹,也患有 DM,在其兄弟确诊后接受了 WS 检查。第三名患者在 5 岁时被诊断出患有 DM,并分别在 7 岁和 12 岁时出现双侧感音神经性听力损失和 OA。所有患者的初步诊断均通过 WFS1 基因的 Sanger 测序得到证实。结果发现了两个以前报道过的基因突变和一个新的基因突变。据我们所知,第一例患者被诊断患有先前在 WS 患者中描述过的注意缺陷多动障碍,而第二例患者的强迫症则是先前在 WS 患者中从未报道过的。我们在第一例患者中发现了青春期延迟,并被诊断为青春期和生长发育的宪法性延迟:结论:早期诊断 WS 可以及早发现相关病症,减少并发症、发病率和死亡率。
{"title":"OBSESSIVE COMPULSIVE DISORDER AND CONSTITUTIONAL DELAY OF GROWTH AND PUBERTY IN WOLFRAM SYNDROME: NEW ASPECTS AND A NOVEL WFS1 MUTATION.","authors":"H Manyas, B Eroğlu Filibeli, I Ayrancı, Ö Kırbıyık, G Catli, B N Dundar","doi":"10.4183/aeb.2024.107","DOIUrl":"10.4183/aeb.2024.107","url":null,"abstract":"<p><strong>Introduction: </strong>Wolfram Syndrome (WS) is a rare autosomal recessively inherited disorder characterized by juvenile-onset diabetes mellitus (DM), diabetes insipidus, optic atrophy (OA), hearing loss and neurodegeneration. This report describes three cases with WS.</p><p><strong>Case report: </strong>The first case was diagnosed with DM and OA at the age of 6 and 11 years, respectively. Second patient was the sibling of the first patient, also had DM and was investigated for WS after his brothers' diagnosis. The third patient was diagnosed with DM at the age of 5 years and developed bilateral sensorineural hearing loss and OA at the ages of 7 and 12 years, respectively. Preliminary diagnoses of all patients were confirmed by Sanger sequencing of the WFS1 gene. Two previously reported and a novel mutation were detected. While our first patient was diagnosed with attention deficit hyperactivity disorder previously described in WS patients, obsessive compulsive disorder observed in case 2, was not previously reported in WS to the best of our knowledge. Puberty delay was detected in our first patient and was diagnosed as constitutional delay of puberty and growth.</p><p><strong>Conclusion: </strong>Early diagnosis of WS can lead to early detection of associated pathologies and to decrease complications, morbidity and mortality.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"107-112"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449251/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE INDEPENDENT EFFECTS OF TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON BONE TURNOVER MARKERS. 2 型糖尿病和慢性肾病对骨转换标志物的独立影响。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.27
I C Mogos, D A Niculescu, R Dusceac, C Poiana

Background: Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are associated with disturbed mineral homeostasis and serum bone biomarkers. The interplay between T2DM and CKD on serum bone turnover markers (BTM) is unclear. Our aim was to describe the BTM in patients with T2DM, CKD or both.

Methods: In this observational, single-centre, prospective study, we included 320 patients over 40 years, divided into four groups: T2DM and normal kidney function (n=142), T2DM and CKD (n=36), CKD and normal glucose metabolism (n=29) and healthy controls (n=113). We excluded patients treated for osteoporosis and with secondary osteoporosis. Patients were compared by age, levels of glycated hemoglobin, PTH, alkaline phosphatase, osteocalcin (OC), CTx and 25 OH vitamin D.

Results: Univariate analysis showed that GFR correlated significantly with PTH (r=0.37), OC (r=0.43) and CTX (r=0.45) in the diabetes group but only with PTH (r=0.34) in the non-T2DM group. Multivariate analysis showed that GFR remained significantly correlated with the same bone markers even after adjustment for age, sex or 25(OH)D levels. Diabetics seem to have lower levels of alkaline phosphatase (68±22.1 U/L) and CTX (0.37±0.24 ng/mL) than those without diabetes (76.7±29.6. U/L and 0.5±0.19 ng/mL, respectively). There was no correlation between BTM and glycated hemoglobin.

Conclusions: Bone turnover markers correlate with GFR, particularly in patients with T2DM. However, alkaline phosphatase is lower in T2DM than in non-T2DM.

背景:慢性肾脏病(CKD)和 2 型糖尿病(T2DM)与矿物质平衡紊乱和血清骨生物标志物有关。T2DM 和 CKD 对血清骨转换标志物 (BTM) 的相互作用尚不清楚。我们的目的是描述 T2DM、CKD 或两者患者的骨转换标志物:在这项观察性、单中心、前瞻性研究中,我们将 320 名 40 岁以上的患者分为四组:T2DM 和肾功能正常组(142 人)、T2DM 和 CKD 组(36 人)、CKD 和糖代谢正常组(29 人)以及健康对照组(113 人)。我们排除了接受骨质疏松症治疗的患者和继发性骨质疏松症患者。通过年龄、糖化血红蛋白水平、PTH、碱性磷酸酶、骨钙素(OC)、CTx 和 25 OH 维生素 D 对患者进行比较:单变量分析显示,糖尿病组的 GFR 与 PTH(r=0.37)、OC(r=0.43)和 CTX(r=0.45)显著相关,但非 T2DM 组仅与 PTH(r=0.34)相关。多变量分析表明,即使对年龄、性别或 25(OH)D 水平进行调整后,GFR 仍与相同的骨标记物存在显著相关性。糖尿病患者的碱性磷酸酶(68±22.1 U/L)和CTX(0.37±0.24 ng/mL)水平似乎低于非糖尿病患者(分别为76.7±29.6 U/L和0.5±0.19 ng/mL)。BTM与糖化血红蛋白之间没有相关性:结论:骨转换标志物与 GFR 相关,尤其是在 T2DM 患者中。然而,T2DM 患者的碱性磷酸酶低于非 T2DM 患者。
{"title":"THE INDEPENDENT EFFECTS OF TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON BONE TURNOVER MARKERS.","authors":"I C Mogos, D A Niculescu, R Dusceac, C Poiana","doi":"10.4183/aeb.2024.27","DOIUrl":"10.4183/aeb.2024.27","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are associated with disturbed mineral homeostasis and serum bone biomarkers. The interplay between T2DM and CKD on serum bone turnover markers (BTM) is unclear. Our aim was to describe the BTM in patients with T2DM, CKD or both.</p><p><strong>Methods: </strong>In this observational, single-centre, prospective study, we included 320 patients over 40 years, divided into four groups: T2DM and normal kidney function (n=142), T2DM and CKD (n=36), CKD and normal glucose metabolism (n=29) and healthy controls (n=113). We excluded patients treated for osteoporosis and with secondary osteoporosis. Patients were compared by age, levels of glycated hemoglobin, PTH, alkaline phosphatase, osteocalcin (OC), CTx and 25 OH vitamin D.</p><p><strong>Results: </strong>Univariate analysis showed that GFR correlated significantly with PTH (r=0.37), OC (r=0.43) and CTX (r=0.45) in the diabetes group but only with PTH (r=0.34) in the non-T2DM group. Multivariate analysis showed that GFR remained significantly correlated with the same bone markers even after adjustment for age, sex or 25(OH)D levels. Diabetics seem to have lower levels of alkaline phosphatase (68±22.1 U/L) and CTX (0.37±0.24 ng/mL) than those without diabetes (76.7±29.6. U/L and 0.5±0.19 ng/mL, respectively). There was no correlation between BTM and glycated hemoglobin.</p><p><strong>Conclusions: </strong>Bone turnover markers correlate with GFR, particularly in patients with T2DM. However, alkaline phosphatase is lower in T2DM than in non-T2DM.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"27-32"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE PLACE OF SURGERY IN THE MANAGEMENT OF PROLACTIN SECRETING ADENOMAS. 手术在催乳素分泌腺瘤治疗中的地位。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.65
D I Rotariu, B Costachescu, M C Ungureanu, L Eva, L Leustean, C Preda, C Cristea, B F Iliescu

Introduction: Surgery has lost a lot of ground as the main therapy of most prolactinomas as it is clear from the current guidelines in most prolactin secreting adenomas, even in the setting of optic compression. However, we believe that surgery is still an important part in the treatment of this type of adenomas. This study is aimed to define what is the role of pituitary surgery in the current setup of prolactinoma management.

Material and methods: In this retrospective, single-center study we analyzed 12 consecutive patients who underwent primary endoscopic transsphenoidal surgery for prolactinomas, between 2013 and 2022. Surgical indication, previous dopamine agonist (DA) treatment, remission rates, surgical complications, pituitary function and imagistic appearance are presented.

Results: Of the 12 patients included, 4 had giant PRL and 8 macroadenomas, while 9 of them had previous DA treatment. The main surgical indication was pituitary apoplexy in 5 patients followed by CSF leak after DA treatment, 3 cases, and DA resistance in 3 cases. The main surgical complications were transitory diabetes insipidus in 7 cases. Normalization of prolactin levels was achieved in 2 patients.

Conclusions: Surgical intervention should be strongly considered in all patients with neurologic symptoms referable to the lesion, resistance to medical therapy, other treatment failure or with complications after DA treatment. The endoscopic endonasal surgery offers good surgical outcomes with low rates of surgical complications and should remain an open option for specific cases.

导言:手术作为大多数催乳素瘤的主要治疗手段已经失去了很大的优势,这一点从目前大多数催乳素分泌腺瘤的治疗指南中可以清楚地看出,即使在视神经受压的情况下也是如此。不过,我们认为手术仍是治疗这类腺瘤的重要手段。本研究旨在明确垂体手术在当前泌乳素瘤治疗中的作用:在这项回顾性单中心研究中,我们分析了2013年至2022年期间因泌乳素瘤而接受内窥镜经蝶手术的12例连续患者。研究结果显示了手术指征、既往多巴胺受体激动剂(DA)治疗、缓解率、手术并发症、垂体功能和影像学外观:在纳入的12名患者中,4人患有巨大PRL,8人患有大腺瘤,其中9人曾接受过DA治疗。5例患者的主要手术指征是垂体卒中,其次是DA治疗后的CSF渗漏(3例)和DA抵抗(3例)。主要的手术并发症是7例短暂性糖尿病。2例患者的泌乳素水平恢复正常:结论:所有出现与病变有关的神经症状、对药物治疗耐药、其他治疗失败或在DA治疗后出现并发症的患者都应积极考虑手术治疗。内窥镜鼻内镜手术具有良好的手术效果和较低的手术并发症发生率,应继续作为特殊病例的开放性选择。
{"title":"THE PLACE OF SURGERY IN THE MANAGEMENT OF PROLACTIN SECRETING ADENOMAS.","authors":"D I Rotariu, B Costachescu, M C Ungureanu, L Eva, L Leustean, C Preda, C Cristea, B F Iliescu","doi":"10.4183/aeb.2024.65","DOIUrl":"10.4183/aeb.2024.65","url":null,"abstract":"<p><strong>Introduction: </strong>Surgery has lost a lot of ground as the main therapy of most prolactinomas as it is clear from the current guidelines in most prolactin secreting adenomas, even in the setting of optic compression. However, we believe that surgery is still an important part in the treatment of this type of adenomas. This study is aimed to define what is the role of pituitary surgery in the current setup of prolactinoma management.</p><p><strong>Material and methods: </strong>In this retrospective, single-center study we analyzed 12 consecutive patients who underwent primary endoscopic transsphenoidal surgery for prolactinomas, between 2013 and 2022. Surgical indication, previous dopamine agonist (DA) treatment, remission rates, surgical complications, pituitary function and imagistic appearance are presented.</p><p><strong>Results: </strong>Of the 12 patients included, 4 had giant PRL and 8 macroadenomas, while 9 of them had previous DA treatment. The main surgical indication was pituitary apoplexy in 5 patients followed by CSF leak after DA treatment, 3 cases, and DA resistance in 3 cases. The main surgical complications were transitory diabetes insipidus in 7 cases. Normalization of prolactin levels was achieved in 2 patients.</p><p><strong>Conclusions: </strong>Surgical intervention should be strongly considered in all patients with neurologic symptoms referable to the lesion, resistance to medical therapy, other treatment failure or with complications after DA treatment. The endoscopic endonasal surgery offers good surgical outcomes with low rates of surgical complications and should remain an open option for specific cases.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"65-73"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GIANT PROLACTINOMA IN A PATIENT WITH GERMLINE SDHB MUTATION. 一名生殖系 Sdhb 基因突变患者的巨大催乳素瘤。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.115
J V Rocha, E Amaro, A Gomes, M J Bugalho
{"title":"GIANT PROLACTINOMA IN A PATIENT WITH GERMLINE SDHB MUTATION.","authors":"J V Rocha, E Amaro, A Gomes, M J Bugalho","doi":"10.4183/aeb.2024.115","DOIUrl":"https://doi.org/10.4183/aeb.2024.115","url":null,"abstract":"","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"115-116"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NEW-ONSET PRIMARY ADRENAL INSUFFICIENCY AFTER COVID-19: CASE REPORT. 新发原发性肾上腺皮质功能不全(Covid-19 后):病例报告。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.90
Y Kayhan, L Azizova, E K Kan, A Atmaca, R Çolak

COVID-19 primarily affects the respiratory system. What comes after the disease is now a greater concern for the scientific world. It is remarkable for causing endocrine organ involvement, particularly in the adrenal glands. However, its effect on the adrenal gland has not been fully elucidated. A case of primary adrenal insufficiency after COVID-19. A 31-year-old female patient who presented with complaints of weakness, anorexia, nausea, recent onset of vomiting, dizziness, and low blood pressure for two months was admitted to the outpatient Department of Endocrinology and Metabolism. After discharge, the patient had routine follow-ups, and here we present the information on the first and seventh month after discharge. The patient was diagnosed with primary adrenal insufficiency with cortisol <0.054 µg/dL and adrenocorticotropic hormone >1200 pg/mL in the laboratory. In the non-contrast computed tomography taken in the adrenal protocol, the stem and leaves of both adrenal glands are significantly thinned and appear atrophic, the right adrenal gland is hardly distinguished. Hydrocortisone was started. All complaints were resolved within a week, except hyperpigmentation, which was resolved six months later after treatment. Our study support adrenal gland involvement due to COVID-19, further research is needed to obtain data on damage mechanisms.

COVID-19 主要影响呼吸系统。目前,科学界更关注的是这种疾病的后遗症。COVID-19 的显著特点是会累及内分泌器官,尤其是肾上腺。然而,它对肾上腺的影响尚未完全阐明。一例服用 COVID-19 后出现原发性肾上腺功能不全的病例。一名 31 岁的女性患者主诉乏力、厌食、恶心、近期出现呕吐、头晕和低血压两个月,被内分泌与代谢科门诊部收治。出院后,患者接受了常规随访,我们在此介绍出院后第一个月和第七个月的情况。患者被诊断为原发性肾上腺功能不全,实验室检测皮质醇为 1200 pg/mL。在肾上腺方案的非对比计算机断层扫描中,两个肾上腺的茎叶明显变薄并出现萎缩,右侧肾上腺几乎无法分辨。开始使用氢化可的松。除色素沉着外,所有症状均在一周内消失,色素沉着在治疗六个月后消失。我们的研究支持 COVID-19 导致的肾上腺受累,但还需要进一步研究,以获得有关损害机制的数据。
{"title":"NEW-ONSET PRIMARY ADRENAL INSUFFICIENCY AFTER COVID-19: CASE REPORT.","authors":"Y Kayhan, L Azizova, E K Kan, A Atmaca, R Çolak","doi":"10.4183/aeb.2024.90","DOIUrl":"10.4183/aeb.2024.90","url":null,"abstract":"<p><p>COVID-19 primarily affects the respiratory system. What comes after the disease is now a greater concern for the scientific world. It is remarkable for causing endocrine organ involvement, particularly in the adrenal glands. However, its effect on the adrenal gland has not been fully elucidated. A case of primary adrenal insufficiency after COVID-19. A 31-year-old female patient who presented with complaints of weakness, anorexia, nausea, recent onset of vomiting, dizziness, and low blood pressure for two months was admitted to the outpatient Department of Endocrinology and Metabolism. After discharge, the patient had routine follow-ups, and here we present the information on the first and seventh month after discharge. The patient was diagnosed with primary adrenal insufficiency with cortisol <0.054 µg/dL and adrenocorticotropic hormone >1200 pg/mL in the laboratory. In the non-contrast computed tomography taken in the adrenal protocol, the stem and leaves of both adrenal glands are significantly thinned and appear atrophic, the right adrenal gland is hardly distinguished. Hydrocortisone was started. All complaints were resolved within a week, except hyperpigmentation, which was resolved six months later after treatment. Our study support adrenal gland involvement due to COVID-19, further research is needed to obtain data on damage mechanisms.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"90-92"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UTILITY OF THE 2023 BETHESDA SYSTEM AUS SUBCATEGORIZATION ON THYROID ASPIRATES. 2023 bethesda 系统 aus 对甲状腺抽吸物进行亚分类的实用性。
IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-10-03 DOI: 10.4183/aeb.2024.1
S Saharti, S Samargandy

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is widely used for the standardized reporting of thyroid fine-needle aspiration (FNA) cytology. The 2023 revision of TBSRTC introduced specific subcategories for the classification of atypia of undetermined significance (AUS). This study tests the association between AUS subtypes and malignant diagnoses, namely AUS-nuclear atypia and AUS-other, in archived thyroid - FNA specimens with atypia from 2018-2022 at King Abdulaziz University Hospital. A total of 104 thyroid - FNA specimens with AUS were re-evaluated cytologically and correlated with subsequent surgical outcomes, along with a discussion of discrepant cases.

贝塞斯达甲状腺细胞病理学报告系统(TBSRTC)被广泛用于甲状腺细针穿刺(FNA)细胞学的标准化报告。TBSRTC的2023年修订版引入了意义未定的不典型性(AUS)分类的特定子类别。本研究检测了阿卜杜勒阿齐兹国王大学医院2018-2022年归档的甲状腺-FNA不典型性标本中AUS亚型与恶性诊断(即AUS-核不典型性和AUS-其他)之间的关联。共对104例甲状腺-FNA标本的AUS进行了细胞学重新评估,并将其与随后的手术结果进行了关联,同时对差异病例进行了讨论。
{"title":"UTILITY OF THE 2023 BETHESDA SYSTEM AUS SUBCATEGORIZATION ON THYROID ASPIRATES.","authors":"S Saharti, S Samargandy","doi":"10.4183/aeb.2024.1","DOIUrl":"10.4183/aeb.2024.1","url":null,"abstract":"<p><p>The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is widely used for the standardized reporting of thyroid fine-needle aspiration (FNA) cytology. The 2023 revision of TBSRTC introduced specific subcategories for the classification of atypia of undetermined significance (AUS). This study tests the association between AUS subtypes and malignant diagnoses, namely AUS-nuclear atypia and AUS-other, in archived thyroid - FNA specimens with atypia from 2018-2022 at King Abdulaziz University Hospital. A total of 104 thyroid - FNA specimens with AUS were re-evaluated cytologically and correlated with subsequent surgical outcomes, along with a discussion of discrepant cases.</p>","PeriodicalId":50902,"journal":{"name":"Acta Endocrinologica-Bucharest","volume":"20 1","pages":"1-4"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Endocrinologica-Bucharest
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1